Compare Baxter International Inc (BAX) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? Baxter International Inc trades at $22.16 (market cap $11.26B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $17.17. The key difference: Baxter International Inc pays a 0.92% dividend while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF pays none, and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is trading nearer its 52-week high, Baxter International Inc nearer its low. Which is the better fit depends on your goals.
| BAX | PDBC | |
|---|---|---|
Market Cap | $11.26B | — |
Sector | Health | — |
52-Week High | $29.22 | $18.91 |
52-Week Low | $15.80 | $12.90 |
Enterprise Value | $18.93B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
PDBC trades at $16.90, up 2.8% today, with a bullish technical signal supported by moving averages and strong momentum indicators. The ETF has delivered significant returns, including 37% since March 2024, outperforming the S&P 500. Recent news highlights its role as a diversified commodity strategy without K-1 tax forms, attracting institutional interest despite variable dividend payouts tied to commodity prices.
The outlook remains positive due to ongoing commodity strength and geopolitical supply risks, but investors face volatility from fluctuating distributions and potential momentum shifts. Key risks include oil price sensitivity and roll costs, while institutional activity shows mixed signals with some reducing positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
